flufenamic acid has been researched along with tamoxifen in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Buttar, D; Colclough, N; Gerhardt, S; MacFaul, PA; Maskos, K; Phillips, SD; Plowright, A; Steinbacher, S; Steuber, H; Tam, K; Whittamore, P | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Jung, MW; Kang, YS; Kim, JA; Lee, SH; Lee, YS | 1 |
| Cho, SJ; Jin, NG; Jung, HC; Kim, JK; Kim, JM; Kim, KW; Koh, EJ; So, I; Yang, DK | 1 |
1 review(s) available for flufenamic acid and tamoxifen
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
8 other study(ies) available for flufenamic acid and tamoxifen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Topics: Binding Sites; Crystallography, X-Ray; Drug Interactions; Humans; Pharmaceutical Preparations; Protein Binding; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Involvement of Ca2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells.
Topics: Apoptosis; Calcium; Calcium Channel Blockers; Cell Survival; Chelating Agents; DNA Fragmentation; Dose-Response Relationship, Drug; Egtazic Acid; Extracellular Space; Flufenamic Acid; Fluorescent Dyes; Fura-2; Hepatoblastoma; Humans; Intracellular Fluid; Ion Channels; Liver Neoplasms; Manganese; Membrane Potentials; Receptors, Estrogen; Signal Transduction; Tamoxifen; Tumor Cells, Cultured | 1999 |
Fundamental role of ClC-3 in volume-sensitive Cl- channel function and cell volume regulation in AGS cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Antibodies; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biophysical Phenomena; Biophysics; Cell Line; Cell Size; Chloride Channels; Chlorides; Electrophysiology; Estrogen Antagonists; Flufenamic Acid; Gastric Mucosa; HeLa Cells; Humans; Hypotonic Solutions; Ion Channels; Nitrobenzoates; RNA, Messenger; Tamoxifen | 2003 |